{"slideshow_credits": null, "snippet": "The $2.6 billion all-cash deal would be the largest for Valeant since its creation in 2010.", "abstract": "Valeant Pharmaceuticals International agrees to buy Medicis Pharmaceutical for about $2.6 billion.", "section_name": "Business Day", "print_page": "6", "document_type": "article", "byline": {"person": [{"firstname": "Bloomberg", "role": "reported", "lastname": "NEWS", "rank": 1, "organization": ""}], "original": "By BLOOMBERG NEWS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/09/04/business/valeant-to-buy-medicis-maker-of-dermatology-drugs.html", "lead_paragraph": "The $2.6 billion all-cash deal would be the largest for Valeant since its creation in 2010.", "headline": {"seo": "Valeant to Buy Medicis, Maker of Dermatology Drugs", "main": "Valeant to Buy Medicis, Maker of Dermatology Drugs", "print_headline": "Valeant to Buy Medicis, Maker of Dermatology Drugs"}, "_id": "53fa821a38f0d8431914d8bc", "word_count": "359", "multimedia": [], "pub_date": "2012-09-04T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Mergers, Acquisitions and Divestitures", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "Medicis Pharmaceutical Corporation", "name": "organizations", "is_major": "Y", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "News"}